First Cholesterol-Lowering Pill to Replace PCSK9 Injections Gets US Nod

The US FDA has given the green light to the world’s first oral PCSK9 inhibitor, a groundbreaking medication that promises a convenient once-daily tablet alternative to injections for managing high cholesterol in adults, particularly those with genetic variations. When combined with other treatments, this innovative drug has shown a significant reduction in bad cholesterol levels. Unfortunately, it may not be available in India right away.